E6 molecular variants of human papillomavirus (HPV) type 16: An updated and unified criterion for clustering and nomenclature

Virology

Volumn 410, Issue 1, 2011, Pages 201-215

  Huertas Salgado, Antonio ^a,b   Martín Gámez, Diana C ^a,b   Moreno, Pablo ^a   Murillo, Raúl ^a   Bravo, María Mercedes ^a   Villa, Luisa ^c   Molano, Mónica ^a,b  

^a Instituto Nacional de Cancerología   (Colombia)

^b UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

^c LUDWIG INSTITUTE FOR CANCER RESEARCH   (Brazil)

Author keywords

E6; HPV 16; Molecular variants; Taxonomic determination

Indexed keywords

PROTEIN E6;

AFRICA; AMINO ACID ANALYSIS; AMINO ACID SEQUENCE; ARTICLE; ASIA; EUROPE; GENE MUTATION; HUMAN PAPILLOMAVIRUS TYPE 16; NONHUMAN; NORTH AMERICA; NUCLEIC ACID BASE SUBSTITUTION; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; POINT MUTATION; PRIORITY JOURNAL; TAXONOMY;

HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 78650730325     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2010.10.039     Document Type: Article

References (116)

1. Agrawal Y., Koch W.M., Xiao W., Westra W.H., Trivett A.L., Symer D.E., Gillison M.L. Oral human papillomavirus infection before and after treatment for human papillomavirus 16-positive and human papillomavirus 16-negative head and neck squamous cell carcinoma. Clin. Cancer Res. 2008, 14:7143-7150.
2. Alemi M., Andersson S., Sallstrom J., Wilander E. Rapid test for identification of a human papillomavirus 16 E6 L83V variant. Diagn. Mol. Pathol. 1999, 8:97-100.
3. Andersson S., Alemi M., Rylander E., Strand A., Larsson B., Sallstrom J., Wilander E. Uneven distribution of HPV 16 E6 prototype and variant (L83V) oncoprotein in cervical neoplastic lesions. Br. J. Cancer 2000, 83:307-310.
4. Asadurian Y., Kurilin H., Lichtig H., Jackman A., Gonen P., Tommasino M., Zehbe I., Sherman L. Activities of human papillomavirus 16 E6 natural variants in human keratinocytes. J. Med. Virol. 2007, 79:1751-1760.
5. Bernard H.U. The clinical importance of the nomenclature, evolution and taxonomy of human papillomaviruses. J. Clin. Virol. 2005, 32(Suppl 1):S1-S6.
6. Bernard H.U., Chan S.Y., Manos M.M., Ong C.K., Villa L.L., Delius H., Peyton C.L., Bauer H.M., Wheeler C.M. Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J. Infect. Dis. 1994, 170:1077-1085.
7. Bernard H.U., Calleja-Macias I.E., Dunn S.T. Genome variation of human papillomavirus types: phylogenetic and medical implications. Int. J. Cancer 2006, 118:1071-1076.
8. Bernard H.U., Burk R.D., Chen Z., van Doorslaer K., Hausen H., de Villiers E.M. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 2010, 401:70-79.
9. Berumen J., Ordonez R.M., Lazcano E., Salmeron J., Galvan S.C., Estrada R.A., Yunes E., Garcia-Carranca A., Gonzalez-Lira G., Madrigal-de la Campa A. Asian-American variants of human papillomavirus 16 and risk for cervical cancer: a case-control study. J. Natl Cancer Inst. 2001, 93:1325-1330.
10. Beskow A.H., Engelmark M.T., Magnusson J.J., Gyllensten U.B. Interaction of host and viral risk factors for development of cervical carcinoma in situ. Int. J. Cancer 2005, 117:690-692.
11. Bhattacharjee B., Mandal N.R., Roy S., Sengupta S. Characterization of sequence variations within HPV16 isolates among Indian women: prediction of causal role of rare non-synonymous variations within intact isolates in cervical cancer pathogenesis. Virology 2008, 377:143-150.
12. Bosch F.X., Manos M.M., Munoz N., Sherman M., Jansen A.M., Peto J., Schiffman M.H., Moreno V., Kurman R., Shah K.V. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J. Natl Cancer Inst. 1995, 87:796-802.
13. Boscolo-Rizzo P., Da Mosto M.C., Fuson R., Frayle-Salamanca H., Trevisan R., Del M.A. HPV-16 E6 L83V variant in squamous cell carcinomas of the upper aerodigestive tract. J. Cancer Res. Clin. Oncol. 2009, 135:559-566.
14. Brady C.S., Duggan-Keen M.F., Davidson J.A., Varley J.M., Stern P.L. Human papillomavirus type 16 E6 variants in cervical carcinoma: relationship to host genetic factors and clinical parameters. J. Gen. Virol. 1999, 80(Pt 12):3233-3240.
15. Buonaguro F.M., Tornesello M.L., Salatiello I., Okong P., Buonaguro L., Beth-Giraldo E., Biryahwaho B., Sempala S.D., Giraldo G. The Uganda study on HPV variants and genital cancers. J. Clin. Virol. 2000, 19:31-41.
16. Burk R.D., Terai M., Gravitt P.E., Brinton L.A., Kurman R.J., Barnes W.A., Greenberg M.D., Hadjimichael O.C., Fu L., McGowan L., Mortel R., Schwartz P.E., Hildesheim A. Distribution of human papillomavirus types 16 and 18 variants in squamous cell carcinomas and adenocarcinomas of the cervix. Cancer Res. 2003, 63:7215-7220.
17. Cai H.B., Chen C.C., Ding X.H. Human papillomavirus type 16 E6 gene variations in Chinese population. Eur. J. Surg. Oncol. 2010, 36:160-163.
18. Cento V., Ciccozzi M., Ronga L., Perno C.F., Ciotti M. Genetic diversity of human papillomavirus type 16 E6, E7, and L1 genes in Italian women with different grades of cervical lesions. J. Med. Virol. 2009, 81:1627-1634.
19. Chakrabarti O., Veeraraghavalu K., Tergaonkar V., Liu Y., Androphy E.J., Stanley M.A., Krishna S. Human papillomavirus type 16 E6 amino acid 83 variants enhance E6-mediated MAPK signaling and differentially regulate tumorigenesis by notch signaling and oncogenic Ras. J. Virol. 2004, 78:5934-5945.
20. Chan P.K., Lam C.W., Cheung T.H., Li W.W., Lo K.W., Chan M.Y., Cheung J.L., Xu L.Y., Cheng A.F. Human papillomavirus type 16 intratypic variant infection and risk for cervical neoplasia in southern China. J. Infect. Dis. 2002, 186:696-700.
21. Chaturvedi A.K., Brinkman J.A., Gaffga A.M., Dumestre J., Clark R.A., Braly P.S., Dunlap K., Kissinger P.J., Hagensee M.E. Distribution of human papillomavirus type 16 variants in human immunodeficiency virus type 1-positive and -negative women. J. Gen. Virol. 2004, 85:1237-1241.
22. Chen Z., Terai M., Fu L., Herrero R., DeSalle R., Burk R.D. Diversifying selection in human papillomavirus type 16 lineages based on complete genome analyses. J. Virol. 2005, 79:7014-7023.
23. Choi B.S., Kim S.S., Yun H., Jang D.H., Lee J.S. Distinctive distribution of HPV16 E6 D25E and E7 N29S intratypic Asian variants in Korean commercial sex workers. J. Med. Virol. 2007, 79:426-430.
24. Chopjitt P., Ekalaksananan T., Pientong C., Kongyingyoes B., Kleebkaow P., Charoensri N. Prevalence of human papillomavirus type 16 and its variants in abnormal squamous cervical cells in Northeast Thailand. Int. J. Infect. Dis. 2009, 13:212-219.
25. Chow V.T., Loh E., Yeo W.M., Tan S.Y., Chan R. Identification of multiple genital HPV types and sequence variants by consensus and nested type-specific PCR coupled with cycle sequencing. Pathology 2000, 32:204-208.
26. Cruz M.R., Cerqueira D.M., Cruz W.B., Camara G.N., Brigido M.M., Silva E.O., Carvalho L.G., Martins C.R. Prevalence of human papillomavirus type 16 variants in the Federal District, Central Brazil. Mem. Inst. Oswaldo Cruz 2004, 99:281-282.
27. Da Costa M.M., Hogeboom C.J., Holly E.A., Palefsky J.M. Increased risk of high-grade anal neoplasia associated with a human papillomavirus type 16 E6 sequence variant. J. Infect. Dis. 2002, 185:1229-1237.
28. de Araujo Souza P.S., Maciag P.C., Ribeiro K.B., Petzl-Erler M.L., Franco E.L., Villa L.L. Interaction between polymorphisms of the human leukocyte antigen and HPV-16 variants on the risk of invasive cervical cancer. BMC Cancer 2008, 8:246.
29. de Boer M.A., Peters L.A., Aziz M.F., Siregar B., Cornain S., Vrede M.A., Jordanova E.S., Kolkman-Uljee S., Fleuren G.J. Human papillomavirus type 16 E6, E7, and L1 variants in cervical cancer in Indonesia, Suriname, and The Netherlands. Gynecol. Oncol. 2004, 94:488-494.
30. de Villiers E.M., Fauquet C., Broker T.R., Bernard H.U., zur H.H. Classification of papillomaviruses. Virology 2004, 324:17-27.
31. DeFilippis V.R., Ayala F.J., Villarreal L.P. Evidence of diversifying selection in human papillomavirus type 16 E6 but not E7 oncogenes. J. Mol. Evol. 2002, 55:491-499.
32. DeFilippis R.A., Goodwin E.C., Wu L., DiMaio D. Endogenous human papillomavirus E6 and E7 proteins differentially regulate proliferation, senescence, and apoptosis in HeLa cervical carcinoma cells. J. Virol. 2003, 77:1551-1563.
33. Ellis J.R., Keating P.J., Baird J., Hounsell E.F., Renouf D.V., Rowe M., Hopkins D., Duggan-Keen M.F., Bartholomew J.S., Young L.S. The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer. Nat. Med. 1995, 1:464-470.
34. Eriksson A., Herron J.R., Yamada T., Wheeler C.M. Human papillomavirus type 16 variant lineages characterized by nucleotide sequence analysis of the E5 coding segment and the E2 hinge region. J. Gen. Virol. 1999, 80(Pt 3):595-600.
35. Etherington I.J., Ellis J.R., Luesley D.M., Moffitt D.D., Young L.S. Histologic and immunologic associations of an HPV16 variant in LoSIL smears. Gynecol. Oncol. 1999, 72:56-59.
36. Gemignani F., Landi S., Chabrier A., Smet A., Zehbe I., Canzian F., Tommasino M. Generation of a DNA microarray for determination of E6 natural variants of human papillomavirus type 16. J. Virol. Meth. 2004, 119:95-102.
37. Gheit T., Simoes R.T., Tommasino M., Donadi E.A., Goncalves M.A. HPV16 variants in squamous intraepithelial lesions in human immunodeficiency virus-negative and -positive Brazilian women. Viral Immunol. 2006, 19:340-345.
38. Gillison M.L., Koch W.M., Capone R.B., Spafford M., Westra W.H., Wu L., Zahurak M.L., Daniel R.W., Viglione M., Symer D.E., Shah K.V., Sidransky D. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J. Natl Cancer Inst. 2000, 92:709-720.
39. Gostout B.S., Zanetta G.M., Maleemonkol S., Kamat M.R., McGovern R.M., Persing D.H. Differential distribution of sequence variations in HPV-16 E6. Gynecol. Oncol. 2000, 79:11-17.
40. Grodzki M., Besson G., Clavel C., Arslan A., Franceschi S., Birembaut P., Tommasino M., Zehbe I. Increased risk for cervical disease progression of French women infected with the human papillomavirus type 16 E6-350G variant. Cancer Epidemiol. Biomark. Prev. 2006, 15:820-822.
41. Hildesheim A., Schiffman M., Bromley C., Wacholder S., Herrero R., Rodriguez A., Bratti M.C., Sherman M.E., Scarpidis U., Lin Q.Q., Terai M., Bromley R.L., Buetow K., Apple R.J., Burk R.D. Human papillomavirus type 16 variants and risk of cervical cancer. J. Natl Cancer Inst. 2001, 93:315-318.
42. Ho L., Chan S.Y., Chow V., Chong T., Tay S.K., Villa L.L., Bernard H.U. Sequence variants of human papillomavirus type 16 in clinical samples permit verification and extension of epidemiological studies and construction of a phylogenetic tree. J. Clin. Microbiol. 1991, 29:1765-1772.
43. Ho L., Chan S.Y., Burk R.D., Das B.C., Fujinaga K., Icenogle J.P., Kahn T., Kiviat N., Lancaster W., Mavromara-Nazos P. The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations. J. Virol. 1993, 67:6413-6423.
44. Ho L., Tay S.K., Chan S.Y., Bernard H.U. Sequence variants of human papillomavirus type 16 from couples suggest sexual transmission with low infectivity and polyclonality in genital neoplasia. J. Infect. Dis. 1993, 168:803-809.
45. Hoffmann M., Lohrey C., Hunziker A., Kahn T., Schwarz E. Human papillomavirus type 16 E6 and E7 genotypes in head-and-neck carcinomas. Oral Oncol. 2004, 40:520-524.
46. Hu X., Pang T., Guo Z., Mazurenko N., Kisseljov F., Ponten J., Nister M. HPV16 E6 gene variations in invasive cervical squamous cell carcinoma and cancer in situ from Russian patients. Br. J. Cancer 2001, 84:791-795.
47. Hu X., Pang T., Guo Z., Ponten J., Nister M., Bernard A.G. Oncogene lineages of human papillomavirus type 16 E6, E7 and E5 in preinvasive and invasive cervical squamous cell carcinoma. J. Pathol. 2001, 195:307-311.
48. Junes-Gill K., Sichero L., Maciag P.C., Mello W., Noronha V., Villa L.L. Human papillomavirus type 16 variants in cervical cancer from an admixtured population in Brazil. J. Med. Virol. 2008, 80:1639-1645.
49. Kammer C., Tommasino M., Syrjanen S., Delius H., Hebling U., Warthorst U., Pfister H., Zehbe I. Variants of the long control region and the E6 oncogene in European human papillomavirus type 16 isolates: implications for cervical disease. Br. J. Cancer 2002, 86:269-273.
50. Kang S., Jeon Y.T., Kim J.W., Park N.H., Song Y.S., Kang S.B., Lee H.P. Polymorphism in the E6 gene of human papillomavirus type 16 in the cervical tissues of Korean women. Int. J. Gynecol. Cancer 2005, 15:107-112.
51. Lee K., Magalhaes I., Clavel C., Briolat J., Birembaut P., Tommasino M., Zehbe I. Human papillomavirus 16 E6, L1, L2 and E2 gene variants in cervical lesion progression. Virus Res. 2008, 131:106-110.
52. Lichtig H., Algrisi M., Botzer L.E., Abadi T., Verbitzky Y., Jackman A., Tommasino M., Zehbe I., Sherman L. HPV16 E6 natural variants exhibit different activities in functional assays relevant to the carcinogenic potential of E6. Virology 2006, 350:216-227.
53. Londesborough P., Ho L., Terry G., Cuzick J., Wheeler C., Singer A. Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities. Int. J. Cancer 1996, 69:364-368.
54. Lopez-Revilla R., Pineda M.A., Ortiz-Valdez J., Sanchez-Garza M., Riego L. Human papillomavirus type 16 variants in cervical intraepithelial neoplasia and invasive carcinoma in San Luis Potosi City, Mexico. Infect. Agent Cancer 2009, 4:3.
55. Lurchachaiwong W., Junyangdikul P., Payungporn S., Chansaenroj J., Sampathanukul P., Tresukosol D., Termrungruanglert W., Theamboonlers A., Poovorawan Y. Entire genome characterization of human papillomavirus type 16 from infected Thai women with different cytological findings. Virus Genes 2009, 39:30-38.
56. Luxton J., Mant C., Greenwood B., Derias N., Nath R., Shepherd P., Cason J. HPV16 E6 oncogene variants in women with cervical intraepithelial neoplasia. J. Med. Virol. 2000, 60:337-341.
57. Matsumoto K., Yoshikawa H., Nakagawa S., Tang X., Yasugi T., Kawana K., Sekiya S., Hirai Y., Kukimoto I., Kanda T., Taketani Y. Enhanced oncogenicity of human papillomavirus type 16 (HPV16) variants in Japanese population. Cancer Lett. 2000, 156:159-165.
58. Matsumoto K., Yasugi T., Nakagawa S., Okubo M., Hirata R., Maeda H., Yoshikawa H., Taketani Y. Human papillomavirus type 16 E6 variants and HLA class II alleles among Japanese women with cervical cancer. Int. J. Cancer 2003, 106:919-922.
59. Meissner J.D. Nucleotide sequences and further characterization of human papillomavirus DNA present in the CaSki, SiHa and HeLa cervical carcinoma cell lines. J. Gen. Virol. 1999, 80(Pt 7):1725-1733.
60. Moreno-Acosta P., Molano M., Huertas A., de Gomez M.S., Romero A., Gonzalez M., Mercedes B.M., Garcia-Carranca A. A non-radioactive PCR-SSCP analysis allows to distinguish between HPV 16 European and Asian-American variants in squamous cell carcinomas of the uterine cervix in Colombia. Virus Genes 2008, 37:22-30.
61. Muller M., Gissmann L., Cristiano R.J., Sun X.Y., Frazer I.H., Jenson A.B., Alonso A., Zentgraf H., Zhou J. Papillomavirus capsid binding and uptake by cells from different tissues and species. J. Virol. 1995, 69:948-954.
62. Munoz N., Bosch F.X., de Sanjose S., Herrero R., Castellsague X., Shah K.V., Snijders P.J., Meijer C.J. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J. Med. 2003, 348:518-527.
63. Myers G., Androphy E. The E6 Protein. Human Papillomaviruses 1995: a compilation and analysis of nucleic acid and amino acid sequences 1995, III-47-III-57.
64. Myers G., Baker C., Wheeler C., Halpern A., McBride A., Doorbar J. A survey of HPV variants. Human Papillomaviruses 1996: a compilation and analysis of nucleic acid and amino acid sequences 1996, I-43-I-185.
65. Ndisang D., Faulkes D.J., Gascoyne D., Lee S.A., Ripley B.J., Sindos M., Singer A., Budhram-Mahadeo V., Cason J., Latchman D.S. Differential regulation of different human papilloma virus variants by the POU family transcription factor Brn-3a. Oncogene 2006, 25:51-60.
66. Nindl I., Rindfleisch K., Lotz B., Schneider A., Durst M. Uniform distribution of HPV 16 E6 and E7 variants in patients with normal histology, cervical intra-epithelial neoplasia and cervical cancer. Int. J. Cancer 1999, 82:203-207.
67. Nindl I., Zumbach K., Pawlita M., Teller K., Schneider A., Durst M. Absence of antibody against human papillomavirus type 16 E6 and E7 in patients with cervical cancer is independent of sequence variations. J. Infect. Dis. 2000, 181:1764-1767.
68. Ordonez R.M., Espinosa A.M., Sanchez-Gonzalez D.J., Armendariz-Borunda J., Berumen J. Enhanced oncogenicity of Asian-American human papillomavirus 16 is associated with impaired E2 repression of E6/E7 oncogene transcription. J. Gen. Virol. 2004, 85:1433-1444.
69. Ortiz M., Torres M., Munoz L., Fernandez-Garcia E., Canals J., Cabornero A.I., Aguilar E., Ballesteros J., Del Amo J., Garcia-Saiz A. Oncogenic human papillomavirus (HPV) type distribution and HPV type 16 E6 variants in two Spanish population groups with different levels of HPV infection risk. J. Clin. Microbiol. 2006, 44:1428-1434.
70. Pande S., Jain N., Prusty B.K., Bhambhani S., Gupta S., Sharma R., Batra S., Das B.C. Human papillomavirus type 16 variant analysis of E6, E7, and L1 genes and long control region in biopsy samples from cervical cancer patients in north India. J. Clin. Microbiol. 2008, 46:1060-1066.
71. Perez-Gallego L., Moreno-Bueno G., Sarrio D., Suarez A., Gamallo C., Palacios J. Human papillomavirus-16 E6 variants in cervical squamous intraepithelial lesions from HIV-negative and HIV-positive women. Am. J. Clin. Pathol. 2001, 116:143-148.
72. Picconi M.A., Alonio L.V., Sichero L., Mbayed V., Villa L.L., Gronda J., Campos R., Teyssie A. Human papillomavirus type-16 variants in Quechua aboriginals from Argentina. J. Med. Virol. 2003, 69:546-552.
73. Pillai M.R., Hariharan R., Babu J.M., Lakshmi S., Chiplunkar S.V., Patkar M., Tongaonkar H., Dinshaw K., Jayshree R.S., Reddy B.K., Siddiqui M., Roychoudury S., Saha B., Abraham P., Gnanamony M., Peedicayil A., Subhashini J., Ram T.S., Dey B., Sharma C., Jain S.K., Singh N. Molecular variants of HPV-16 associated with cervical cancer in Indian population. Int. J. Cancer 2009, 125:91-103.
74. Pista A., Oliveira A., Barateiro A., Costa H., Verdasca N., Paixao M.T. Molecular variants of human papillomavirus type 16 and 18 and risk for cervical neoplasia in Portugal. J. Med. Virol. 2007, 79:1889-1897.
75. Qiu A.D., Wu E.Q., Yu X.H., Jiang C.L., Jin Y.H., Wu Y.G., Chen Y., Chen Y., Shan Y.M., Zhang G.N., Fan Y., Zha X., Kong W. HPV prevalence, E6 sequence variation and physical state of HPV16 isolates from patients with cervical cancer in Sichuan, China. Gynecol. Oncol. 2007, 104:77-85.
76. Quint K.D., de Koning M.N., van Doorn L.J., Quint W.G., Pirog E.C. HPV genotyping and HPV16 variant analysis in glandular and squamous neoplastic lesions of the uterine cervix. Gynecol. Oncol. 2010, 117:297-301.
77. Radhakrishna P.M., Sreevidya S., Pollock B.H., Jayaprakash P.G., Herman B. Human papillomavirus type 16 E6 and E7 gene variations in Indian cervical cancer. Gynecol. Oncol. 2002, 87:268-273.
78. Rajeevan M.S., Swan D.C., Nisenbaum R., Lee D.R., Vernon S.D., Ruffin M.T., Horowitz I.R., Flowers L.C., Kmak D., Tadros T., Birdsong G., Husain M., Srivastava S., Unger E.R. Epidemiologic and viral factors associated with cervical neoplasia in HPV-16-positive women. Int. J. Cancer 2005, 115:114-120.
79. Refugio Gonzalez-Losa M., Laviada M., Puerto-Solis M., Garcia-Carranca A. Molecular variants of HPV type 16 E6 among Mexican women with LSIL and invasive cancer. J. Clin. Virol. 2004, 29:95-98.
80. Richard C., Lanner C., Naryzhny S.N., Sherman L., Lee H., Lambert P.F., Zehbe I. The immortalizing and transforming ability of two common human papillomavirus 16 E6 variants with different prevalences in cervical cancer. Oncogene 2010, 29:3435-3445.
81. Sathish N., Abraham P., Peedicayil A., Sridharan G., Chandy G. HPV 16 E6 sequence variations in Indian patients with cervical neoplasia. Cancer Lett. 2005, 229:93-99.
82. Schlecht N.F., Burk R.D., Palefsky J.M., Minkoff H., Xue X., Massad L.S., Bacon M., Levine A.M., Anastos K., Gange S.J., Watts D.H., Da Costa M.M., Chen Z., Bang J.Y., Fazzari M., Hall C., Strickler H.D. Variants of human papillomaviruses 16 and 18 and their natural history in human immunodeficiency virus-positive women. J. Gen. Virol. 2005, 86:2709-2720.
83. Sichero L., Ferreira S., Trottier H., Duarte-Franco E., Ferenczy A., Franco E.L., Villa L.L. High grade cervical lesions are caused preferentially by non-European variants of HPVs 16 and 182. Int. J. Cancer 2007, 120:1763-1768.
84. Sichero L., Trottier H., Ferreira S., Duarte-Franco E., Franco E.L., Villa L.L. Re: Human papillomavirus type 16 and 18 variants: race-related distribution and persistence. J. Natl Cancer Inst. 2007, 99:653-654.
85. Stephen A.L., Thompson C.H., Tattersall M.H., Cossart Y.E., Rose B.R. Analysis of mutations in the URR and E6/E7 oncogenes of HPV 16 cervical cancer isolates from central China. Int. J. Cancer 2000, 86:695-701.
86. Stoppler M.C., Ching K., Stoppler H., Clancy K., Schlegel R., Icenogle J. Natural variants of the human papillomavirus type 16 E6 protein differ in their abilities to alter keratinocyte differentiation and to induce p53 degradation. J. Virol. 1996, 70:6987-6993.
87. Swan D.C., Rajeevan M., Tortolero-Luna G., Follen M., Tucker R.A., Unger E.R. Human papillomavirus type 16 E2 and E6/E7 variants. Gynecol. Oncol. 2005, 96:695-700.
88. Swan D.C., Limor J.R., Duncan K.L., Rajeevan M.S., Unger E.R. Human papillomavirus type 16 variant assignment by pyrosequencing. J. Virol. Meth. 2006, 136:166-170.
89. Tabora N., Bakkers J.M., Quint W.G., Massuger L.F., Matute J.A., Melchers W.J., Ferrera A. Human papillomavirus infection in Honduran women with normal cytology. Cancer Causes Control 2009, 20:1663-1670.
90. Tao M., Kruhlak M., Xia S., Androphy E., Zheng Z.M. Signals that dictate nuclear localization of human papillomavirus type 16 oncoprotein E6 in living cells. J. Virol. 2003, 77:13232-13247.
91. Tonon S.A., Basiletti J., Badano I., Alonio L.V., Villa L.L., Teyssie A.R., Picconi M.A. Human papillomavirus type 16 molecular variants in Guarani Indian women from Misiones, Argentina. Int. J. Infect. Dis. 2007, 11:76-81.
92. Tornesello M.L., Buonaguro F.M., Meglio A., Buonaguro L., Beth-Giraldo E., Giraldo G. Sequence variations and viral genomic state of human papillomavirus type 16 in penile carcinomas from Ugandan patients. J. Gen. Virol. 1997, 78(Pt 9):2199-2208.
93. Tornesello M.L., Duraturo M.L., Salatiello I., Buonaguro L., Losito S., Botti G., Stellato G., Greggi S., Piccoli R., Pilotti S., Stefanon B., De Palo G., Franceschi S., Buonaguro F.M. Analysis of human papillomavirus type-16 variants in Italian women with cervical intraepithelial neoplasia and cervical cancer. J. Med. Virol. 2004, 74:117-126.
94. Tornesello M.L., Duraturo M.L., Giorgi-Rossi P., Sansone M., Piccoli R., Buonaguro L., Buonaguro F.M. Human papillomavirus (HPV) genotypes and HPV16 variants in human immunodeficiency virus-positive Italian women. J. Gen. Virol. 2008, 89:1380-1389.
95. Tornesello M.L., Duraturo M.L., Losito S., Botti G., Pilotti S., Stefanon B., De P.G., Gallo A., Buonaguro L., Buonaguro F.M. Human papillomavirus genotypes and HPV16 variants in penile carcinoma. Int. J. Cancer 2008, 122:132-137.
96. Tu J.J., Kuhn L., Denny L., Beattie K.J., Lorincz A., Wright T.C. Molecular variants of human papillomavirus type 16 and risk for cervical neoplasia in South Africa. Int. J. Gynecol. Cancer 2006, 16:736-742.
97. van Duin M., Snijders P.J., Vossen M.T., Klaassen E., Voorhorst F., Verheijen R.H., Helmerhorst T.J., Meijer C.J., Walboomers J.M. Analysis of human papillomavirus type 16 E6 variants in relation to p53 codon 72 polymorphism genotypes in cervical carcinogenesis. J. Gen. Virol. 2000, 81:317-325.
98. Villa L.L., Sichero L., Rahal P., Caballero O., Ferenczy A., Rohan T., Franco E.L. Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. J. Gen. Virol. 2000, 81:2959-2968.
99. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., Snijders P.J., Peto J., Meijer C.J., Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 1999, 189:12-19.
100. Watts K.J., Thompson C.H., Cossart Y.E., Rose B.R. Sequence variation and physical state of human papillomavirus type 16 cervical cancer isolates from Australia and New Caledonia. Int. J. Cancer 2002, 97:868-874.
101. Wheeler C.M., Yamada T., Hildesheim A., Jenison S.A. Human papillomavirus type 16 sequence variants: identification by E6 and L1 lineage-specific hybridization. J. Clin. Microbiol. 1997, 35:11-19.
102. Wu Y., Chen Y., Li L., Yu G., He Y., Zhang Y. Analysis of mutations in the E6/E7 oncogenes and L1 gene of human papillomavirus 16 cervical cancer isolates from China. J. Gen. Virol. 2006, 87:1181-1188.
103. Wu Y., Liu B., Lin W., Xu Y., Li L., Zhang Y., Chen S., Xu A. HPV16 E6 variants and HLA class II polymorphism among Chinese women with cervical cancer. J. Med. Virol. 2007, 79:439-446.
104. Xi L.F., Demers G.W., Koutsky L.A., Kiviat N.B., Kuypers J., Watts D.H., Holmes K.K., Galloway D.A. Analysis of human papillomavirus type 16 variants indicates establishment of persistent infection. J. Infect. Dis. 1995, 172:747-755.
105. Xi L.F., Koutsky L.A., Galloway D.A., Kuypers J., Hughes J.P., Wheeler C.M., Holmes K.K., Kiviat N.B. Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia. J. Natl Cancer Inst. 1997, 89:796-802.
106. Xi L.F., Critchlow C.W., Wheeler C.M., Koutsky L.A., Galloway D.A., Kuypers J., Hughes J.P., Hawes S.E., Surawicz C., Goldbaum G., Holmes K.K., Kiviat N.B. Risk of anal carcinoma in situ in relation to human papillomavirus type 16 variants. Cancer Res. 1998, 58:3839-3844.
107. Xi L.F., Kiviat N.B., Hildesheim A., Galloway D.A., Wheeler C.M., Ho J., Koutsky L.A. Human papillomavirus type 16 and 18 variants: race-related distribution and persistence. J. Natl Cancer Inst. 2006, 98:1045-1052.
108. Yamada T., Wheeler C.M., Halpern A.L., Stewart A.C., Hildesheim A., Jenison S.A. Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments. J. Virol. 1995, 69:7743-7753.
109. Yamada T., Manos M.M., Peto J., Greer C.E., Munoz N., Bosch F.X., Wheeler C.M. Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J. Virol. 1997, 71:2463-2472.
110. Zehbe I., Voglino G., Delius H., Wilander E., Tommasino M. Risk of cervical cancer and geographical variations of human papillomavirus 16 E6 polymorphisms. Lancet 1998, 352:1441-1442.
111. Zehbe I., Wilander E., Delius H., Tommasino M. Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. Cancer Res. 1998, 58:829-833.
112. Zehbe I., Tachezy R., Mytilineos J., Voglino G., Mikyskova I., Delius H., Marongiu A., Gissmann L., Wilander E., Tommasino M. Human papillomavirus 16 E6 polymorphisms in cervical lesions from different European populations and their correlation with human leukocyte antigen class II haplotypes. Int. J. Cancer 2001, 94:711-716.
113. Zehbe I., Voglino G., Wilander E., Delius H., Marongiu A., Edler L., Klimek F., Andersson S., Tommasino M. p53 codon 72 polymorphism and various human papillomavirus 16 E6 genotypes are risk factors for cervical cancer development. Cancer Res. 2001, 61:608-611.
114. Zehbe I., Mytilineos J., Wikstrom I., Henriksen R., Edler L., Tommasino M. Association between human papillomavirus 16 E6 variants and human leukocyte antigen class I polymorphism in cervical cancer of Swedish women. Hum. Immunol. 2003, 64:538-542.
115. Zehbe I., Richard C., DeCarlo C.A., Shai A., Lambert P.F., Lichtig H., Tommasino M., Sherman L. Human papillomavirus 16 E6 variants differ in their dysregulation of human keratinocyte differentiation and apoptosis. Virology 2009, 383:69-77.
116. Zuna R.E., Moore W.E., Shanesmith R.P., Dunn S.T., Wang S.S., Schiffman M., Blakey G.L., Teel T. Association of HPV16 E6 variants with diagnostic severity in cervical cytology samples of 354 women in a US population. Int. J. Cancer 2009, 125:2609-2613.